Abstract
Mitochondria are maternally inherited organelles that play critical tissue-specific roles, including hormone synthesis and energy production, that influence development, health, and aging. However, whether mitochondria from women and men exhibit consistent biological differences remains unclear, representing a major gap in biomedical knowledge. This meta-analysis systematically examined 4 domains and 6 subdomains of mitochondrial biology (total 39 measures), including mitochondrial content, respiratory capacity, reactive oxygen species (ROS) production, morphometry, and mitochondrial DNA copy number. Standardized effect sizes (Hedge’s g) of sex differences were computed for each measure using data in 2,258 participants (51.5% women) from 50 studies. Only two measures demonstrated aggregate binary sex differences: higher mitochondrial content in women (g = 0.20, χ2 p = 0.01), and higher ROS production in skeletal muscle in men (g = 0.49, χ2 p < 0.0001). differences showed weak to Sex no correlation with age or BMI. Studies with small sample sizes tended to overestimate effect sizes (r = -0.17, p < 0.001), and sex differences varied by tissue examined. Our findings point to a wide variability of findings in the literature concerning possible binary sex differences in mitochondrial biology. Studies specifically designed to capture sex- and gender-related differences in mitochondrial biology are needed, including detailed considerations of physical activity and sex hormones.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Work of the authors was supported by FRQS grant 297877 to G.G., the Wharton Fund to A.J. and M.P., and NIH grants MH119336, AG066828, MH122706, and MH123927 to M.P.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The source data for this study are openly available and can be accessed in Supplemental file 2.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data for this study are openly available and can be accessed in Supplemental file 2.
Nonstandard abbreviations
- CI
- complex I, NADH dehydrogenase
- CII
- complex II, succinate dehydrogenase
- CIII
- complex III, ubiquinol-cytochrome c reductase
- CIV
- complex IV, cytochrome c oxidase
- CV
- complex V, ATP synthase
- CS
- citrate synthase
- GHT
- gender-affirming hormone therapy
- mtDNA
- mitochondrial DNA
- mtDNAcn
- mitochondrial DNA copy number
- MRS
- magnetic resonance spectroscopy
- OxPhos
- Oxidative phosphorylation
- PBMCs
- peripheral blood mononuclear cells
- ROS
- reactive oxygen species
- TGD
- transgender and gender diverse
